Additionally, a previous report demonstrated that O-glycosylation profile of MUC2 mucin is altered in UC patients and its alteration is associated with mucosal inflammation level, implying that O-glycosylation pattern of MUC2 mucin is involved in the pathology of IBD [116]. Here, MUC2 is linked to inflammatory bowel disease.